Las reacciones opuestas en el metabolismo de la coenzima A sensibilizan a la inhibición de la enzima Mycobacterium tuberculosis

Video Experimental Relacionado

Updated: Jan 30, 2026

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

Elaine Ballinger¹, John Mosior², Travis Hartman³

¹Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.

Science (New York, N.Y.)

|February 2, 2019

Resumen

Un nuevo compuesto inhibe la fosfopanteinila transferasa (PptT), una enzima clave en la síntesis de lípidos de Mycobacterium tuberculosis. Esta inhibición, potenciada por la Ppt hidrolasa (PptH), ofrece una nueva estrategia contra la tuberculosis.

Área de la Ciencia:

Microbiología
La bioquímica
Descubrimiento de drogas

Sus antecedentes:

El Mycobacterium tuberculosis (Mtb) es una de las principales causas de muerte infecciosa en humanos.
La pared celular y la virulencia de Mtb dependen de la síntesis de lípidos, dependiente de la fosfopanteinila transferasa (PptT).
El PptT transfiere la 4'-fosfopanteteína (Ppt) de la coenzima A (CoA) a las proteínas portadoras de acilo.

Objetivo del estudio:

Para identificar y caracterizar un compuesto que inhibe la PptT.
Investigar el papel de la Ppt hidrolasa (PptH) en la respuesta de Mtb a la inhibición de la PptT.
Para explorar un nuevo objetivo terapéutico para la tuberculosis.

Principales métodos:

Evaluación de compuestos para la inhibición de PptT.
Ensayos bioquímicos para evaluar la actividad y la inhibición de las enzimas.
Cristalografía para determinar la estructura del complejo inhibidor de PptT.
El análisis genético de los mutantes de PptH.

Principales resultados:

Se identificó un compuesto que inhibe parcialmente PptT y mata Mtb.
La eficacia del compuesto es potenciada por PptH, que invierte la reacción PptT.
Las mutaciones de pérdida de función en PptH confieren resistencia al compuesto.
Se obtuvo una estructura cocristalina de PptT y el inhibidor.

Conclusiones:

El PptT es un objetivo farmacológico viable para los nuevos agentes antimicobáceos.
Las acciones opuestas de PptT y PptH revelan una vía reguladora en el metabolismo de CoA.
La estructura del inhibidor de PptT proporciona una base para el desarrollo de nuevos tratamientos para la tuberculosis.

Más Videos Relacionados

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis

Separation and Fractionation of Cell Wall and Cell Membrane Proteins from Mycobacterium tuberculosis for Downstream Protein Analysis

Published on: September 26, 2025

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

Videos de Conceptos Relacionados

Enzyme Inhibition

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.

Cofactors and Coenzymes

Cofactors and Coenzymes

Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.

Cofactors and Coenzymes

Cofactors and Coenzymes

Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...

Feedback Inhibition

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!

Drug Metabolism: Phase I Reactions

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...

Drug Metabolism: Phase II Reactions

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...